Significant reduction of Mac-2 binding protein glycosylation isomer (M2BPGi) protein level in patients who achieved sustained virological response (SVR) but those could not by the combination therapy of daclatasvir/asunaprevir
(米国消化器病学会週間 DDW2018 2018)